Logo image of ZVSA

ZYVERSA THERAPEUTICS INC (ZVSA) Stock Analyst Earnings Estimates

NASDAQ:ZVSA - Nasdaq - US98987D3008 - Common Stock - Currency: USD

1.22  0 (0%)

After market: 1.21 -0.01 (-0.82%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
ZVSA revenue by date.ZVSA revenue by date.
N/AN/AN/AN/AN/AN/A
423.40%
EBITDA
YoY % growth
ZVSA ebitda by date.ZVSA ebitda by date.
-11.823M-7.694M
34.92%
-13.823M
-79.66%
-14.41M
-4.25%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ZVSA ebit by date.ZVSA ebit by date.
-11.833M-7.704M
34.89%
-13.833M
-79.55%
-14.421M
-4.25%
N/A
-15.66%
N/A
-72.14%
N/A
-40.67%
N/A
-36.24%
N/A
-14.07%
N/A
84.51%
Operating Margin
ZVSA operating margin by date.ZVSA operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ZVSA eps by date.ZVSA eps by date.
N/AN/AN/AN/AN/A
97.53%
N/A
93.00%
N/A
-217.07%
N/A
-1,091.03%
N/A
-22.39%
N/A
17.15%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-4.61
96.63%
-0.41
90.99%
-0.41
87.67%
-0.26
89.51%
-0.31
93.36%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-4.692M
-164.16%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-2.43
92.29%
-3.771.3435.61%
Q2 2024
Q2Q % growth
-3.31 -3.830.5213.46%
Q1 2024
Q2Q % growth
-4.53 -3.77-0.76-20.03%
Q4 2023
Q2Q % growth
-136.80 -21.83-114.97-526.72%
Q3 2023
Q2Q % growth
-31.50 -57.1225.6244.85%
ZVSA Yearly EPS VS EstimatesZVSA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 -200 -400 -600
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
ZVSA Yearly Revenue VS EstimatesZVSA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -11.48% 0% -16.71%
RevenueN/A N/A N/A N/A